Archive for November, 2011

Buy Tradjenta (Trajenta)

Monday, November 28th, 2011

Tradjenta, also known as Trajenta in Canada, which is a DPP-4 (dipeptidyl peptidase-4) inhibitor used to treat type 2 diabetes. Tradjenta has been approved by the U.S. Food and Drug Administration to improve blood sugar control in people with type 2 diabetes together with the diet and exercise.

Linagliptin works by blocking the DPP-4 for raising the levels of insulin-stimulating hormones in the body. It can be used on its own or together with metformin, sulfonylurea or pioglitazone.

The most common side effects of Tradjenta were headache, muscle pain, respiratory infection, and sore throat. Take Tradjenta 5 mg tablet once a daily. People with kidney or liver problems do not need to adjust the dose of Tradjenta.

Tradjenta is the new DPP-4 inhibitor will compete with two other drugs in the same class: buy Januvia, buy Onglyza

Share

A Superdrug to Cure any Viral Infections?

Friday, November 25th, 2011

from Extra Super Cutie

A new super drug, called Double-stranded RNA Activated Caspase Oligomerizers (DRACO), is being developed by MIT researchers with its ability to cure almost any viral infections.

Researchers at MIT have been tested the super drug both on human and mice; it is effective against the common cold, flu, dengue fever, polio and a various stomach virus.

The results showed that DRACO has the potential to treat or prevent a wide range of viral infections in safe and effective way. The current antibiotics or antivirals work on individual viruses or have undesirable side effects. However, DRACO provides a novel approach by targeting a kind of generic material known as RNA only in the infected cells. It works by using a cell’s natural defence mechanism to cause the infected cells to commit suicide and prevent duplicating. On the other hand, the healthy cells will be remained unharmed. So far, “Mice has been treated with DRACO were cured of the flu without any adverse effects”, said Todd Rider, a scientist from MIT group.

Researchers are hopeful that the new super drug could be an innovative treatment for new virus like SARS (severe acute respiratory syndrome). It should work against all viruses if in theory.

The test on DRACO will continue moving on larger animals and human clinical trials in the future.

Share

Erectile Dysfunction Linked to Taking More Medications

Thursday, November 24th, 2011

from emaxhealth.com

In a Kaiser Permanente study, the more medications men are taking, the higher risk of their erectile dysfunction (ED). The study surveyed more than 37,000 ages 46 to 69, 29 percent of men had experienced moderate to severe ED problems.

The erectile dysfunction is the also known as impotence when some men has problems achieving or maintaining an erection. Erectile dysfunction can occur or affect men of any age; especially it is common in the elderly. An estimate of 30 million in the US has suffered this embarrassing condition, according to MedicineNet.com.

Medications and ED
It is still not fully understood how taking more medications may increase the risk of ED. But the evidences showed the number of medications men took increased, so did the severity of their erectile dysfunction.

Medications —— Number of Men ——-  Moderate ED
0-2 ———————- 16,126 ——————— 15.9%
3-5  ——————— 10,046 ——————— 19.7%
6-9  ———————-  6,870 ——————— 25.5%
>10  ———————- 4,670 ——————— 30.9%

ED problem can be caused by a variety of factors, including age, depression, diabetes, high cholesterol, hypertension, and smoking history. The pharmacy records showed medications the most commonly prescribed with ED, including antihypertensives (beta blockers, thiazides, and clonidine) and antidepressants (selective serotonin reuptake inhibitors, tricyclics, MAO inhibitors).

Men with ED problems need to speak to the doctors to review the medications they are taking and the potential side effects. A prescription is required for any RX drugs including erection dysfunction medications such as Viagra, Cialis, and Levitra.

Share

Animus Issues Urgent Recall Notice to Insulin Pump Users

Tuesday, November 22nd, 2011

Insulin pump

In a rare development that all insulin dependent diabetics should be aware of, Johnson & Johnson has recalled around 384,000 cartridges for its Animus Insulin Pump.

To date, twenty-two injuries have been reported as a result of faulty insulin pump cartridges leaking at the side where the plunger is. The leaks can result in the diabetic using the cartridge receiving a lower insulin dosage than they intended.

Johnson & Johnson has posted an urgent notice on their Animus division website warning consumers to check their cartridge supply and to stop using any of the 2.0 ml cartridges in question immediately. It is also contacting insulin pump users, or as they refer to them, “insulin pumpers”, that may have purchased the faulty cartridges, and shipping them replacement cartridges. The website notice reads in part:

Please note that under-delivery of insulin can cause high blood sugar and/or diabetic ketoacidosis. These are serious conditions that can cause severe health impact, including death. Symptoms of diabetic ketoacidosis may include nausea, vomiting, shortness of breath and excess thirst/urination. Contact your healthcare professional immediately if you are experiencing any of these symptoms.

Ketoacidosis usually develops slowly over 24 hours, starting with symptoms such as fatigue, mental stupor, decreased appetite, loss of appetite, headache, and fading consciousness. Other ketoacidosis symptoms all insulin dependent diabetics should be aware of include stomach or abdominal pain, a flushed complexion, and breath that smells like fruit or nail polish remover.

The insulin cartridge recall extends to the US and France. The recall applies only to lot numbers B201575, B201576, B201581, B201582 and B201583. The insulin pump cartridges in questions were shipped between November 30th, 2010 and January 4th, 2011.

Animas has provided the following instructions for insulin pumpers diabetics with a recalled insulin cartridge who need to disconnect their infusion sets:

1) Disconnect the infusion set from your body (failure to follow these important safety instructions can lead to unintended delivery of insulin).
2) Unscrew the cartridge cap, leaving the tubing connected to the cartridge.
3) With the tubing connected to the cartridge, pull the cartridge straight out of your insulin pump.
4) Disconnect tubing from cartridge, set the cartridge aside to return to Animas.
5) Fill a new cartridge from an unaffected lot not listed above, and attach infusion set tubing.
6) While still disconnected, rewind, load the cartridge and prime.
7) Connect tubing to site once prime is complete.
8) Fill cannula only if you have inserted a new infusion set.

Animas Customer Support can also be reached by phone toll-free at 877-937-7867.

Share

New Legislation increases Threat to your Health

Monday, November 21st, 2011

— Your Right to Order Prescriptions Online is in Danger —

Misguided efforts by Congress and officials in the White House during the past two years could take away Americans’ ability to order medications online — even from trusted and reputable sources like our website. There are two real and imminent threats to continued access to safe, imported prescription drugs.

The first threat comes from pending legislation in the Senate introduced last May known as the Preventing Real Online Threats to Economic Creativity and Theft of Intellectual Property Act of 2011 (PROTECT IP). You may already be aware of this Bill that attempts to categorize all non-U.S. based online pharmacies as a risk to public health and therefore certain target for shut down. If this bill gets passed, our website and all others that sell Canadian drugs and international medicines to Americans could cease to appear and be prohibited from defending themselves against those who shut them down.

The next threat comes from The House of Representatives in a bill introduced in October titled the Stop Online Piracy Act (SOPA). While SOPA is designed to protect the interests of U.S. businesses and fight counterfeiting, it increases the threatening actions proposed in PROTECT IP and makes them worse. SOPA includes language that inappropriately lumps real licensed pharmacies like ours with rogues.

SOPA makes no effort to distinguish between the good guys like us – legitimate pharmacies that require a doctor’s prescription and sell brand-name medications; and the bad guys – that sell everything from diluted or counterfeit medicine to narcotics without a prescription. Because of this, the bill could shut down the websites of legitimate international pharmacies that offer safe, affordable medications.

The language of SOPA is so vague and broad, that our pharmacy could be shut-down “in the dark of night.” You see, SOPA grants legal immunity to a large list of US companies that have business reasons for wanting us dismantled. They can voluntarily deny service to our legitimate pharmacy businesses without a court order. It empowers hundreds of companies to police the web and shut-down sites based on nothing more than a suspicion of wrongdoing.

PROTECT IP and SOPA are driving legislation toward the White House. These bills play directly into the interests of the Administration, which in December 2010 announced its intention to completely shut down online pharmacy sites by “encouraging” Internet service providers, credit card companies, and search engines to cut off American’s access to them. Passage of these two bills would fulfill this mission.

Many people believe that big pharmaceutical companies are behind these threats. Major drug companies have long tried to persuade the American public that internationally sourced medicines are unsafe. While we agree that drug safety is critical and that rogue pharmacies should be stopped we know that legitimate online pharmacies such as ours should not be punished as a result of these sweeping actions.

There is action you can take to try to prevent this from happening— and we are asking for everyone’s assistance immediately. To voice your concern, join RxRights, a growing coalition of individuals and organizations that are dedicated to protecting and preserving all Americans’ access to safe, affordable medications. You can send an electronic letter directly to your congressional and senate representatives in Washington as well as President Obama through the coalition’s website at www.rxrights.org. Let your elected officials know today that you want and need continued access to affordable medications from safe, licensed online pharmacies like ours. For more information, please visit www.rxrights.org.

Share

Eating Too Quickly Doubles the Risk of Insulin Resistance

Friday, November 18th, 2011

from Quasic

Yet another reason to listen to your mother and slow down and chew your food properly – eating too quickly has been associated with a doubled risk of developing impaired glucose tolerance, or pre-diabetes. As the name suggests, pre-diabetes is the forerunner to developing type 2 diabetes. Most diabetics have type 2 diabetes – a form of diabetes where your body no longer responds properly to insulin (called insulin resistance). Type 2 diabetes used to be described as non insulin dependent diabetes.

Insulin is the hormone that moves sugar (glucose) from the blood to the body’s cells to provide them with energy. If your cells do not use insulin properly, the pancreas produces more insulin that normal to cope with the body’s demands. Eventually, the pancreas cannot keep up, and excess glucose builds up in the bloodstream. Type 2 diabetes is characterized by high levels of glucose in the blood.

A recent Japanese study followed over 170 healthy individuals for three years, monitoring their eating habits. Snacking, eating late at night, skipping meals and eating out were not associated with developing pre-diabetes. The one and only eating habit associated with the development of insulin resistance was eating too quickly.

The researchers aren’t sure why eating faster makes an individual more likely to develop pre-diabetes and type 2 diabetes, but suspect that eating rapidly results in higher post-meal blood glucose levels. Some doctors also point out that eating too quickly results in an overall increase in the amount of calories taken in, and a resulting weight gain. Since it takes about 20 minutes for the brain to receive the signal that the stomach is full, those who eat quickly continue eating without realizing that their stomach is filled.

Previous research has also shown that eating quickly results in increased weight gain. Insulin resistance generally increases with increased body fat, and there is a pronounced connection between obesity and diabetes. The two are so closely connected that it gave rise to the term “diabesity”. Diabesity is currently epidemic across the developed world.

Insulin resistance has no symptoms. Pre-diabetes is sometimes called impaired glucose tolerance, and can be diagnosed with a fasting glucose test or a glucose tolerance test. The American Diabetes Association recommends that adults who are overweight and have one or more additional risk factors for diabetes should consider being tested. Additional risk factors include:

• Having a parent or sibling with diabetes
• Being physically inactive.
• Being African American, Alaska native, American Indian, Asian American, Hispanic or Latino, or a Pacific Islander
• Giving birth to a baby weighing more than 9 pounds or being diagnosed with gestational diabetes
• Having high blood pressure or being treated for high blood pressure
• Low HDL (“good”) cholesterol levels or high triglyceride levels
• Having polycystic ovary syndrome
• Having a history of cardiovascular disease

People with pre-diabetes can avoid becoming diabetic and having to take diabetes medication by losing weight, being physically active, eating a healthy diet, and, as we now know, not eating too quickly.

Share

Buy Dapsone

Friday, November 18th, 2011

Dapsone is a sulphone antibiotic medication available in tablet form used to treat leprosy and a certain skin problem called dermatitis herpetiformis.

Dapsone is also available in gel form, known as Aczone topical gel 5% made by Valeant in Canada. Aczone is relatively new acne medication provides you acne relief with great results.

Before you are planning to buy Dapsone, please visit our product pages for drug information and pricing details.

Share

Hormone Therapy for Breast Cancer

Tuesday, November 15th, 2011

Breast Cancer Yoga Basic Starter...

Breasts contain cells which respond to natural hormones, notably estrogens and progesterone. These cells contain hormone receptors to which these hormones can bind. Some breast cancer cells contain similar receptors, which means that they respond to and grow more quickly in the presence of hormones.

There are two main types of breast cancer: estrogen-receptor-positive (the cancer cells contain estrogen), and estrogen-receptor-negative (no estrogen in the cancer cells). About 60% of breast cancers in pre-menopausal women are hormone-receptor-positive, and about 80% of breast cancers in post-menopausal women are hormone-positive.

The initial biopsy results provide information on the presence or absence of estrogen and/or progesterone sensitive cells, determining what type of breast cancer the patient has. Most women with breast cancer will require surgery. The type of breast cancer, and the stage it is at, will determine the type of treatment, including follow up care.

Estrogen receptor and progesterone receptor positive tumors tend to respond well to chemotherapy, which is usually the treatment of choice for stage III and IV breast cancers.

What is Letrozole?
Breast cancer recurs after surgical treatment in about one of three women with hormone receptor-positive early stage breast cancer. If the cancer was being fueled by the hormones estrogen and/or progesterone, then hormone blockers can help prevent breast cancer recurrence following surgery.

Hormone-sensitive cancer is slightly slower growing, and responds to hormone suppression drugs that block the body’s production of estrogen. Cancer that is not hormone-sensitive requires a different kind of follow up treatment.

Letrozole, marketed as Femara, is an aromatase inhibitor prescribed to decrease the chance of a recurrence of hormone-receptor-positive early stage breast cancer by stopping the production of estrogen. It is intended only for post-menopausal women, and is prescribed as a once daily tablet following surgery.

Other commonly prescribed aromatase inhibitors are anastrolzole (brand name Arimidex), and exemestane (brand name Aromasin).

Side Effects of Letrozole
The more troubling side effects of letrozole include a loss of bone density and an increase in cholesterol. Bone density and cholesterol levels may need to be monitored in some patients.

Many patients do not experience any serious side effects when taking Femara for cancer, but some have reported hot flashes, joint and muscle pain, hair loss, fatigue, sweating, nausea, diarrhea and trouble sleeping.

Femara VS Tamoxifen
Tamoxifen was the “gold standard” in the treatment of breast cancer for postmenopausal women for nearly 30 years. In 1998, a worldwide clinical trial began involving more than 8,000 postmenopausal female breast cancer survivors. Among other things, the study compared the effects of letrozole 2.5 mg tablets vs tamoxifen in postmenopausal women with hormone-receptor-positive early stage breast cancer.

Normally, breast cancer patients continue to take cancer medication for five years following surgery. At a six-year follow-up, Femara was shown to have reduced the reoccurrence of breast cancer by 15% more than tamoxifen. Femara better than the older cancer drug.

As a result of improvements in screening and treatment, breast cancer survival rates have been climbing for years. The highest survival rates for women with stage 1 cancer are in the age group of 50 to 69. The highest survival rates for women with stages 2, 3 and 4 cancer is in the age group of 40 to 49. Overall, survival rates come close to 90%.

Share

Buy Resolor

Wednesday, November 9th, 2011

Results only now reported from a 12-week clinical trial that ended nine years ago suggest that a new drug, Resolor, helps people with chronic constipation.

Meanwhile, promising findings suggest that a new form of naltrexone, a drug used to block the narcotic effects of opioids in addicts, may relieve the terrible constipation that afflicts patients who need opioids to control their pain.

To read a full article of Drugs Ease Hard-To-Treat Constipation, please visit CBSNews.

To buy Resolor online, please check the product details here.

Share

Buy Alimta

Wednesday, November 9th, 2011

Eli Lilly & Co.’s lung cancer drug Alimta may help lengthen lives of patients whose disease is in remission, according to a study that may lead to a new treatment strategy for the malignancy.

Patients either took Alimta or a placebo every 21 days after their disease had been controlled with a standard therapy. People taking the drug lived 3 months longer overall than those on placebo, according to the Indianapolis-based company’s research being presented today at the American Society of Clinical Oncology meeting in Orlando, Florida. To read a full article of Lilly’s Alimta May Help Lung Cancer Patients Live Months Longer, please >click< here.

To buy Alimta online, please check the product details here.

Share